| Literature DB >> 34860303 |
Francisco Alejandro Lagunas-Rangel1.
Abstract
Humanity has always sought to live longer and for this, multiple strategies have been tried with varying results. In this sense, G protein-coupled receptors (GPCRs) may be a good option to try to prolong our life while maintaining good health since they have a substantial participation in a wide variety of processes of human pathophysiology and are one of the main therapeutic targets. In this way, we present the analysis of a series of GPCRs whose activity has been shown to affect the lifespan of animal and human models, and in which we put a special interest in describing the molecular mechanisms involved. Our compilation of data revealed that the mechanisms most involved in the role of GPCRs in lifespan are those that mimic dietary restriction, those related to insulin signaling and the AMPK and TOR pathways, and those that alter oxidative homeostasis and severe and/or chronic inflammation. We also discuss the possibility of using agonist or antagonist drugs, depending on the beneficial or harmful effects of each GPCR, in order to prolong people's lifespan and healthspan.Entities:
Keywords: AMPK pathway; Dietary restriction; GPCR; Healthspan; Insulin signaling; Longevity
Mesh:
Substances:
Year: 2021 PMID: 34860303 PMCID: PMC8888397 DOI: 10.1007/s10522-021-09945-8
Source DB: PubMed Journal: Biogerontology ISSN: 1389-5729 Impact factor: 4.277
GPCRs that have shown effects on lifespan
| GPCR name | Organism | Role in extending lifespan | Effect associated with lifespan | References |
|---|---|---|---|---|
| TAS2R16 | Favors | Alters recognition of beneficial and harmful molecules | Di Bona et al. ( Malovini et al. ( Campa et al. ( | |
| TAS2R38 | Favors | Alters recognition of beneficial and harmful molecules | Melis et al. ( | |
| HTR2A | Favors | Associated with schizophrenia, suicide, impulsivity, and emotional disorders | Jobim et al. ( Fukuda et al. ( | |
| DRD2 | Favors | – | Crocco et al. ( Szekely et al. ( | |
| AGTR2 | Favors | Participates in processes of brain damage and proteinuria | Gelosa et al. ( | |
| ADRA1A | Favors | – | Doze et al. ( | |
| AdipoR1 | Favors | Regulates the AMPK pathway and the CaMKKb-AMPK-SIRT1 axis | Iwabu et al. ( Yamauchi et al. ( | |
| AdipoR2 | Favors | Changes the expression of PPAR-α target genes. Alters fatty acid oxidation and pro-inflammatory cytokine levels | Yamauchi et al. ( | |
| HCRTR2 | Favors | Alters neuronal activity and its beneficial effects | Satoh et al. ( | |
| GPBAR1 | Favors | Controls mechanisms that mimic dietary restriction | Wang et al. ( | |
| DOP-3 | Favors | Controls the release of acetylcholine | Saharia et al. ( | |
| STR-2 | Favors | Required at temperatures ≥ 20 °C. Regulates lipid droplet homeostasis and lipid metabolism | Dixit et al. ( | |
| SRBC-48 | Favors | Protects against infection-associated dendritic degeneration. Avoid uncontrolled activation of immune genes | Kaur and Aballay ( | |
| DAF-37 | Favors | Regulates Sir2.1-dependent mechanisms | Ludewig et al. ( | |
| mGluR | Favors | Controls increases in calcium mediated by the ionotropic glutamate receptor and possibly GH secretion | Ly and Naidoo | |
| TkR99D | Favors | Alters Dilp2 and Dilp3 secretion | Birse et al. ( | |
| BOSS | Favors | Alters oxygen homeostasis | Kohyama-Koganeya et al. ( | |
| CapaR | Favors | Inhibits the release of glucagon-like adipokinetic hormone from the cardiac body Restricts the energy mobilization of adipose tissue and prevents harmful hyperglycemia | Koyama et al. ( | |
| ADRB2 | Disadvantages | – | Zhao et al. ( Gao et al. ( Spindler et al. ( | |
| FSH | Disadvantages | Regulates fertility, activation of BAT and energy expenditure | Corbo et al. ( Liu et al. ( | |
| AGTR1 | Disadvantages | Alters oxidative homeostasis and cardiac and endothelial function. Causes changes in the levels of NAMPT and SIRT3 | Benigni et al. ( Mercier et al. ( Nikiforovich et al. ( Nagura et al. ( | |
| ADRA1B | Disadvantages | – | Collette et al. ( | |
| SER-1 | Disadvantages | Alters resistance to stressors | Murakami and Murakami ( | |
| SER-3 | Disadvantages | Participates in mechanisms that mimic dietary restriction | Zhang et al. ( Petrascheck et al. ( | |
| NPR1 | Disadvantages | Alters oxygen homeostasis | Abergel et al. ( | |
| GAR-3 | Disadvantages | Alters acetylcholine signaling | Lucanic et al. ( | |
| OCTR-1 | Disadvantages | Controls the expression of several immune defense genes | Wibisono et al. ( | |
| OR83B | Disadvantages | Alters resistance to stressors. Controls mechanisms that mimic dietary restriction | Libert et al. ( | |
| CCHa2R | Disadvantages | Regulates insulin release | Jin et al. ( | |
| Mth | Disadvantages | Alters resistance to stressors. Regulates the levels of insulin released and the expression of SODs | Gimenez et al. ( Lin ( | |
| Mthl10 | Disadvantages | Alters Dilp2 secretion and metabolic inflammation | Sung et al. ( |
GPCRs can provide beneficial or harmful effects and therefore affect the lifespan of organisms. The aforementioned organism is where GPCR has been studied the most
Fig. 1Disruption of Mth causes an increase in the lifespan of Drosophila. When Mth levels are reduced in IPCs, the secretion of Dlips is inhibited with a consequent increase in glucose levels in the hemolymph that protects against starvatation. JNK is also promoted to activate FOXO, which translocates to the nucleus where it promotes the transcription of MnSODs and CuZnSODs to increase resistance to oxidative stress and shelf life. TOR activity is inhibited to promote increased lifespan
Fig. 2AdipoRs cooperate to improve lifespan and healthspan, AdipoR1 and AdipoR2 serve as adiponectin receptors and mediate the activation of the AMPK and PPAR pathways, thus regulating glucose and lipid metabolism that cooperates in increasing lifespan